View More Recent Stories

Oct 28, 2024 08:00AM Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets
Oct 24, 2024 10:50AM Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast
Oct 7, 2024 08:00AM Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies
Sep 25, 2024 08:03AM Ainos (AIMD) Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial
Sep 25, 2024 08:00AM Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA
Sep 24, 2024 10:55AM Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome
Sep 23, 2024 08:09AM Ainos (AIMD) Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Sep 23, 2024 08:00AM Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Sep 20, 2024 08:00AM Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
Sep 17, 2024 08:09AM Ainos (AIMD) to Initiate Taiwan Clinical Study for VELDONA
Sep 17, 2024 08:00AM Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
Sep 3, 2024 08:35AM Ainos (AIMD) Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention
Sep 3, 2024 08:30AM Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention
Aug 27, 2024 08:30AM Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Aug 26, 2024 08:30AM Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter
Aug 19, 2024 09:17AM Ainos (AIMD) Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
Aug 19, 2024 09:15AM Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
Aug 12, 2024 08:00AM Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024
Aug 6, 2024 08:30AM Ainos Concludes Growth Financing From Lind Partners
View More Recent Stories